Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Acta Oncologica (Stockholm, Sweden)|September 5, 2022
High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiationMarie Hjälm-Eriksson, Anders Ullén, Sten Nilsson, et al.
Acta Oncologica (Stockholm, Sweden)|October 25, 2021
A biomarker panel predicts recurrence-free survival in ulcerated primary cutaneous melanomaJohan Falkenius, Johanna Keskitalo, Lena Kanter, et al.
Annals of Surgery|October 12, 2018
Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer TreatmentFredrik Lohmander, Jakob Lagergren, Pankaj G Roy, et al.
Leukemia & Lymphoma|May 26, 2020
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapyAnna Asklid, Sandra Eketorp Sylvan, Agnes Mattsson, et al.
Acta Oncologica (Stockholm, Sweden)|March 15, 2011
Difference in hormone receptor content in breast cancers from Vietnamese and Swedish womenVu Hong Thang, Edneia Tani, Hemming Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer. Long-term results from a phase III studyMorten Brændengen, Kjell M Tveit, Marianne J Hjermstad, et al.
Melanoma Research|October 17, 2013
High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanomaJohan Falkenius, Joakim Lundeberg, Hemming Johansson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2012
Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trialMia Fahlén, Tommy Fornander, Hemming Johansson, et al.
Journal of Plastic Surgery and Hand Surgery|January 17, 2022
Clinical assessment of breast symmetry and aesthetic outcome: can 3D imaging be the gold standard?Lucy Bai, Ola Lundström, Hemming Johansson, et al.
Breast Cancer Research and Treatment|April 2, 2020
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancerYvonne Brandberg, Hemming Johansson, Mats Hellström, et al.
Pageof 11